NervGen Pharma Corp (NGEN) — Tangible Net Worth Ratio
NervGen Pharma Corp (NGEN) has a Tangible Net Worth Ratio of 67.5% as of March 2025. This metric is calculated by deducting intangible assets (CA$451.01K) from net assets (CA$1.39 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
NervGen Pharma Corp Tangible Net Worth Ratio (2018–2024)
This chart shows how NervGen Pharma Corp's Tangible Net Worth Ratio has changed across 6 annual periods from 2018 to 2024. As of March 2025, the ratio stands at 67.5%, reflecting net assets of CA$1.39 Million with intangible assets of CA$451.01K CAD. Also explore net asset momentum of NervGen Pharma Corp to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for NervGen Pharma Corp (2018–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for NervGen Pharma Corp from 2018 to 2024, covering 6 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see NGEN company net worth.
| Year | Tangible NW Ratio | Net Assets (CAD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 82.0% | CA$2.58 Million | CA$464.96K | CA$19.49 Million | ▼ -14.8 pp |
| 2022 | 96.8% | CA$13.46 Million | CA$431.40K | CA$23.88 Million | ▼ -0.4 pp |
| 2021 | 97.2% | CA$16.82 Million | CA$473.15K | CA$17.90 Million | ▲ +5.1 pp |
| 2020 | 92.0% | CA$5.92 Million | CA$471.39K | CA$6.68 Million | ▲ +0.8 pp |
| 2019 | 91.3% | CA$5.84 Million | CA$509.61K | CA$6.77 Million | ▲ +13.1 pp |
| 2018 | 78.2% | CA$2.51 Million | CA$547.83K | CA$3.10 Million | — |